Literature DB >> 2513322

Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process.

D R Sell1, V M Monnier.   

Abstract

Isolation and structure elucidation of an acid-resistant fluorescent molecule from human extracellular matrix revealed the presence of an imidazo[4,5-b]pyridinium molecule comprising a lysine and an arginine residue cross-linked by a pentose. Structure confirmation was achieved in vitro by the nonenzymatic reaction of ribose with lysine and arginine residues. The cross-link, named pentosidine, could also be synthesized with isomers of ribose, arabinose, xylose, and lyxose as well as by incubating young human collagen with these sugars at 37 degrees C. Pentosidine was found in a variety of human tissues including plasma proteins and red blood cells. Its presence in cells grown in culture strongly suggests ribose or ribonucleotide metabolites as precursors. The unexpected discovery of pentose-mediated protein cross-linking raises new questions concerning the aging process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513322

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  172 in total

1.  Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).

Authors:  Shahid P Baba; Jason Hellmann; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

2.  Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation.

Authors:  V M Bhor; S Sivakami
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 3.  Trends in advanced glycation end products research in diabetes mellitus and its complications.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-03-23       Impact factor: 3.396

Review 4.  Fluorescence lifetime measurements and biological imaging.

Authors:  Mikhail Y Berezin; Samuel Achilefu
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

5.  ATP-dependent mechanism protects spectrin against glycation in human erythrocytes.

Authors:  Sumie Manno; Narla Mohandas; Yuichi Takakuwa
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

6.  Ribosylation of bovine serum albumin induces ROS accumulation and cell death in cancer line (MCF-7).

Authors:  Mohd Shahnawaz Khan; Sourabh Dwivedi; Medha Priyadarshini; Shams Tabrez; Maqsood Ahmed Siddiqui; Haseeb Jagirdar; Abdulrahman M Al-Senaidy; Abdulaziz A Al-Khedhairy; Javed Musarrat
Journal:  Eur Biophys J       Date:  2013-11-12       Impact factor: 1.733

7.  Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.

Authors:  Richard D Semba; Kai Sun; Ann V Schwartz; Ravi Varadhan; Tamara B Harris; Suzanne Satterfield; Melissa Garcia; Luigi Ferrucci; Anne B Newman
Journal:  J Hypertens       Date:  2015-04       Impact factor: 4.844

8.  Pro-inflammatory effects of early non-enzymatic glycated proteins in human mesothelial cells vary with cell donor's age.

Authors:  L Rodríguez-Mañas; C Sánchez-Rodríguez; S Vallejo; M El-Assar; C Peiró; V Azcutia; N Matesanz; C F Sánchez-Ferrer; J Nevado
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

9.  Diabetes-related changes in the protein composition of rat cerebral microvessels.

Authors:  A D Mooradian; J L Pinnas; C C Lung; M D Yahya; K Meredith
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

10.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

Authors:  A M Schmidt; O Hori; J X Chen; J F Li; J Crandall; J Zhang; R Cao; S D Yan; J Brett; D Stern
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.